{"id":22466,"date":"2018-10-31T15:24:13","date_gmt":"2018-10-31T15:24:13","guid":{"rendered":"https:\/\/corporate.webfactory.ferring.tech\/?p=22466"},"modified":"2021-05-10T17:48:35","modified_gmt":"2021-05-10T16:48:35","slug":"ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer","status":"publish","type":"post","link":"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/","title":{"rendered":"Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer"},"content":{"rendered":"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h2 style=\"color: #0088ce\">Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer<\/h2>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<ul>\n<li>Michel Pettigrew, President of the Executive Board and Chief Operating Officer, will retire from his operational activities, effective December 31, 2018<\/li>\n<\/ul>\n<ul>\n<li>Per Falk will be the next President of the Executive Committee and Chief Science Officer, effective January 1, 2019<\/li>\n<\/ul>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 class=\"p1\" style=\"color: #0088ce\">Saint-Prex, Switzerland \u2013 31 October, 2018 \u2013<\/h3>\n<p class=\"p1\">Ferring Pharmaceuticals today announced that Michel Pettigrew, President of the Executive Board and Chief Operating Officer, will retire from his operational activities effective December 31, 2018. Per Falk, Chief Science Officer, will assume additional responsibility as President of the Executive Committee, effective January 1, 2019.<\/p>\n<p>Michel has had an exceptional career at Ferring, taking the company from revenues of \u20ac345 million when he joined the company in 2001 to nearly \u20ac2 billion today. In addition, Ferring is now in the Top 50 Global Pharma Companies 2018.<\/p>\n<p>\u201cI would like to express my sincere appreciation for Michel\u2019s commitment to Ferring, his considerable achievements and his passion for supporting patients and helping people live better lives,\u201d said Frederik Paulsen, Chairman of the Ferring Board of Directors. \u201cI wish Per every success in his expanded leadership role. With his strong scientific and medical background, Per will lead Ferring with the Executive Committee to its next phase of growth and innovation.\u201d<\/p>\n<p>Per joined Ferring in 2015 and has been instrumental in leading and driving change for R&D and the wider organisation, while ensuring that the business can realise its full potential in the future. In addition, Per has accelerated Ferring\u2019s focus on the microbiome through a number of external collaborations and the recent acquisition of Rebiotix. Prior to joining Ferring, Per worked at Novo Nordisk for 12 years and served in several executive and leadership roles, including R&D and regional commercial leadership teams. Per is a qualified medical doctor and also has a PhD in Biochemistry and Clinical Chemistry.<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 class=\"p1\" style=\"color: #0088ce\">About Ferring Pharmaceuticals<\/h3>\n<p class=\"p1\">Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and women\u2019s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.<\/p>\n<p class=\"p1\">Learn more at\u00a0<a href=\"https:\/\/www.ferring.com\/\">www.ferring.com<\/a>, or connect with us on <a href=\"https:\/\/twitter.com\/ferring\">Twitter<\/a>,\u00a0<a href=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\">Facebook<\/a>,\u00a0<a href=\"https:\/\/www.instagram.com\/ferringpharmaceuticals\/\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.linkedin.com\/company\/ferring-pharmaceuticals\/\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.youtube.com\/channel\/UC6Ss0Uwv54xTGmM_EDEzQPA\">YouTube<\/a>.<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 class=\"p1\" style=\"color: #0088ce\">For more information, please contact<\/h3>\n<p class=\"p1\"><span class=\"s1\"><b>Bhavin Vaid<\/b><\/span><span class=\"s2\"><b><br \/>\n<\/b><\/span><span class=\"s1\"><i>Head of Corporate Communications<\/i><\/span><span class=\"s2\"><b><i><br \/>\n<\/i><\/b><\/span><span class=\"s1\">+41 58 301 09 52 (direct)<\/span><span class=\"s2\"><br \/>\n<\/span><span class=\"s1\">+41 79 191 06 32 (mobile)<\/span><span class=\"s2\"><b><br \/>\n<\/b><a href=\"mailto:bhavin.vaid@ferring.com\"><span class=\"s3\">bhavin.vaid@ferring.com<\/span><\/a><\/span><span class=\"s1\">\u00a0<\/span><\/p>\n<p class=\"p2\"><span class=\"s1\"><b>Lindsey Rodger<\/b><\/span><span class=\"s2\"><b><br \/>\n<\/b><\/span><span class=\"s1\"><i>Senior Manager, Corporate Communications<\/i><\/span><span class=\"s2\"><b><i><br \/>\n<\/i><\/b><\/span><span class=\"s1\">+41 58 451 40 23 (direct)<\/span><span class=\"s2\"><br \/>\n<\/span><span class=\"s1\">+41 79 191 04 86 (mobile)<\/span><span class=\"s2\"><b><br \/>\n<\/b><a href=\"mailto:lindsey.rodger@ferring.com\"><span class=\"s3\">lindsey.rodger@ferring.com<\/span><\/a><\/span><\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_button button_text=”READ MORE PRESS RELEASES” button_size=”standard” button_colour=”accent” button_type=”standard” rounded=”no” button_dropshadow=”no” button_link=”\/media\/press-releases\/” button_target=”_self” align=”center” animation=”none” animation_delay=”0″ width=”1\/1″ el_position=”first last”]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Michel Pettigrew, President of the Executive Board and Chief Operating Officer, will retire from his operational activities, effective December 31, 2018 Per Falk […]<\/p>\n","protected":false},"author":2410,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[243],"tags":[],"class_list":["post-22466","post","type-post","status-publish","format-standard","hentry","category-press-release-2018"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.3 (Yoast SEO v23.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer - Ferring Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer\" \/>\n<meta property=\"og:description\" content=\"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Michel Pettigrew, President of the Executive Board and Chief Operating Officer, will retire from his operational activities, effective December 31, 2018 Per Falk […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Ferring Global\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-31T15:24:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-10T16:48:35+00:00\" \/>\n<meta name=\"author\" content=\"pulse\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ferring\" \/>\n<meta name=\"twitter:site\" content=\"@ferring\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"pulse\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/\"},\"author\":{\"name\":\"pulse\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\"},\"headline\":\"Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer\",\"datePublished\":\"2018-10-31T15:24:13+00:00\",\"dateModified\":\"2021-05-10T16:48:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/\"},\"wordCount\":682,\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"articleSection\":[\"PRESS RELEASE 2018\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/\",\"url\":\"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/\",\"name\":\"Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer - Ferring Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/#website\"},\"datePublished\":\"2018-10-31T15:24:13+00:00\",\"dateModified\":\"2021-05-10T16:48:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ferring.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ferring.com\/#website\",\"url\":\"https:\/\/www.ferring.com\/\",\"name\":\"Ferring Pharmaceuticals\",\"description\":\"Helping people live better lives\",\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ferring.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ferring.com\/#organization\",\"name\":\"Ferring\",\"url\":\"https:\/\/www.ferring.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"contentUrl\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"width\":236,\"height\":154,\"caption\":\"Ferring\"},\"image\":{\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\",\"https:\/\/x.com\/ferring\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\",\"name\":\"pulse\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"caption\":\"pulse\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer - Ferring Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/","og_locale":"en_US","og_type":"article","og_title":"Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer","og_description":"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Michel Pettigrew, President of the Executive Board and Chief Operating Officer, will retire from his operational activities, effective December 31, 2018 Per Falk […]","og_url":"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/","og_site_name":"Ferring Global","article_publisher":"https:\/\/www.facebook.com\/ferringpharmaceuticals\/","article_published_time":"2018-10-31T15:24:13+00:00","article_modified_time":"2021-05-10T16:48:35+00:00","author":"pulse","twitter_card":"summary_large_image","twitter_creator":"@ferring","twitter_site":"@ferring","twitter_misc":{"Written by":"pulse","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/#article","isPartOf":{"@id":"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/"},"author":{"name":"pulse","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d"},"headline":"Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer","datePublished":"2018-10-31T15:24:13+00:00","dateModified":"2021-05-10T16:48:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/"},"wordCount":682,"publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"articleSection":["PRESS RELEASE 2018"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/","url":"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/","name":"Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer - Ferring Global","isPartOf":{"@id":"https:\/\/www.ferring.com\/#website"},"datePublished":"2018-10-31T15:24:13+00:00","dateModified":"2021-05-10T16:48:35+00:00","breadcrumb":{"@id":"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ferring.com\/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ferring.com\/"},{"@type":"ListItem","position":2,"name":"Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.ferring.com\/#website","url":"https:\/\/www.ferring.com\/","name":"Ferring Pharmaceuticals","description":"Helping people live better lives","publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ferring.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ferring.com\/#organization","name":"Ferring","url":"https:\/\/www.ferring.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/","url":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","contentUrl":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","width":236,"height":154,"caption":"Ferring"},"image":{"@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ferringpharmaceuticals\/","https:\/\/x.com\/ferring"]},{"@type":"Person","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d","name":"pulse","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","caption":"pulse"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22466"}],"collection":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/users\/2410"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/comments?post=22466"}],"version-history":[{"count":0,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22466\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/media?parent=22466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/categories?post=22466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/tags?post=22466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}